Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells
Clinical trial NCT04572308 · COMPLETED
Trial details
- NCT number
- NCT04572308
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2021-05-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.